Intranasal Administration of microRNA-146a-5p Agomir Rescued the Pathological Process and Cognitive Impairment in an Alzheimer’s Disease Mouse Model

Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2019.10.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease

Frontiers in Neurology
Neurology
2018English

The Neuritic Plaque Facilitates Pathological Conversion of Tau in an Alzheimer’s Disease Mouse Model

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Cognitive Impairment in the Tg6590 Transgenic Rat Model of Alzheimer’s Disease

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Neuroprotective Effect of Formononetin in Ameliorating Learning and Memory Impairment in Mouse Model of Alzheimer’s Disease

Bioscience, Biotechnology and Biochemistry
Organic ChemistryApplied MicrobiologyMolecular BiologyBiochemistryAnalytical ChemistryMedicineBiotechnology
2017English

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

Archives of Neurology
2012English

The Effects of Bioactive Compounds on Alzheimer’s Disease and Mild Cognitive Impairment

Functional Foods in Health and Disease
2016English

Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2019English

Neuregulin 1 Improves Cognitive Deficits and Neuropathology in an Alzheimer’s Disease Model

Scientific Reports
Multidisciplinary
2016English

Increased EEG Gamma Band Activity in Alzheimer’s Disease and Mild Cognitive Impairment

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy